Chinese Journal of Antituberculosis ›› 2019, Vol. 41 ›› Issue (11): 1167-1172.doi: 10.3969/j.issn.1000-6621.2019.11.005
• Original Articles • Previous Articles Next Articles
WEI Lan,JIA Xin-zhuan,QIN Xue-bo,FENG Jun-peng,LI Yu-zhuo,DUAN Xiao-liang()
Received:
2019-05-13
Online:
2019-11-10
Published:
2019-12-05
WEI Lan,JIA Xin-zhuan,QIN Xue-bo,FENG Jun-peng,LI Yu-zhuo,DUAN Xiao-liang. The value of serum CXC chemokine receptor 3 ligands in the diagnosis of active pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2019, 41(11): 1167-1172. doi: 10.3969/j.issn.1000-6621.2019.11.005
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2019.11.005
一般特征 | PTB组(106例) | PMT组(89例) | PBD组(82例) | HC组(90名) | 统计值 | P值 |
---|---|---|---|---|---|---|
年龄(岁, | 43.03±5.42 | 42.95±5.47 | 44.07±5.40 | 43.18±5.43 | F=0.66 | 0.575 |
性别[例/名(构成比,%)] | χ2=1.00 | 0.801 | ||||
男 | 54(50.9) | 45(50.6) | 47(57.3) | 47(52.2) | ||
女 | 52(49.1) | 44(49.4) | 35(42.7) | 43(47.8) | ||
吸烟史[例/名(构成比,%)] | χ2=1.71 | 0.636 | ||||
有 | 42(39.6) | 31(34.8) | 25(30.5) | 32(35.6) | ||
无 | 64(60.4) | 58(65.2) | 57(69.5) | 58(64.4) | ||
BMI( | 20.08±0.56 | 20.11±0.61 | 20.33±0.48 | 21.10±0.54 | F=0.35 | 0.792 |
检测指标 | PTB组(106例) | PMT组(89例) | PBD组(82例) | HC组(90名) | H值 | P值 |
---|---|---|---|---|---|---|
CXCL9 [pg/ml,M(Q1,Q3)] | 650.28 (220.00,881.21) | 120.21 (33.50,244.28) | 45.52 (15.25,86.55) | 50.11 (28.32,81.22) | 210.29 | 0.000 |
CXCL10 [pg/ml,M(Q1,Q3)] | 390.00 (200.05,500.29) | 58.00 (30.25,85.56) | 55.56 (26.75,86.28) | 50.28 (32.27,70.62) | 189.35 | 0.000 |
CXCL11 [pg/ml,M(Q1,Q3)] | 150.33 (80.12,320.00) | 35.52 (20.27,44.50) | 31.53 (20.50,45.25) | 11.46 (5.28,30.39) | 193.29 | 0.000 |
IFN-γ [pg/ml,M(Q1,Q3)] | 13.00 (8.50,18.25) | 15.11 (8.50,18.00) | 13.02 (9.90,18.28) | 10.86 (7.01,12.00) | 43.10 | 0.000 |
[1] |
Wallis RS, Pai M, Menzies D , et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet, 2010,375(9729):1920-1937.
doi: 10.1016/S0140-6736(10)60359-5 URL pmid: 20488517 |
[2] |
Wallis RS, Kim P, Cole S , et al. Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect Dis, 2013,13(4):362-372.
doi: 10.1016/S1473-3099(13)70034-3 URL |
[3] |
Koguchi Y, Kawakami K, Uezu K , et al. High plasma osteopontin level and its relationship with interleukin-12-media-ted type 1 T-helper cell response in tuberculosis. Am J Respir Crit Care Med, 2003,167(10):1355-1359.
doi: 10.1164/rccm.200209-1113OC URL pmid: 12574077 |
[4] |
Andersen P, Munk ME, Pollock JM , et al. Specific immunebased diagnosis of tuberculosis. Lancet, 2000,356(9235):1099-1104.
doi: 10.1016/s0140-6736(00)02742-2 URL pmid: 11009160 |
[5] |
Sester M, Sotgiu G, Lange C , et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J, 2011,37(1):100-111.
doi: 10.1183/09031936.00114810 URL |
[6] |
Ruhwald M, Bodmer T, Maier C , et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J, 2008,32(6):1607-1615.
doi: 10.1183/09031936.00055508 URL pmid: 18684849 |
[7] |
Hong JY, Jung GS, Kim H , et al. Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis. Int J Infect Dis, 2012,16(12):e855-859.
doi: 10.1016/j.ijid.2012.07.013 URL pmid: 22959355 |
[8] | 魏兰, 秦学博, 段小亮 , 等. 血干扰素诱导蛋白10检测对判断肺结核患者治疗效果的价值. 中国防痨杂志, 2019,41(2):181-185. |
[9] |
Cole KE, Strick CA, Paradis TJ , et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med, 1998,187(12):2009-2021.
doi: 10.1084/jem.187.12.2009 URL pmid: 9625760 |
[10] |
Loetscher P, Pellegrino A, Gong JH , et al. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem, 2001,276(5):2986-2991.
doi: 10.1074/jbc.M005652200 URL pmid: 11110785 |
[11] | 中华人民共和国国家卫生和计划生育委员会.WS 288—2017 肺结核诊断. 2017 -11-09. |
[12] |
Groom JR, Luster AD . CXCR3 in T cell function. Exp Cell Res, 2011,317(5):620-631.
doi: 10.1016/j.yexcr.2010.12.017 URL pmid: 21376175 |
[13] |
Sakai S, Kauffman KD, Schenkel JM , et al. Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells. J Immunol, 2014,192(7):2965-2969.
doi: 10.4049/jimmunol.1400019 URL pmid: 24591367 |
[14] |
Arlehamn CL, Seumois G, Gerasimova A , et al. Transcriptional profile of tuberculosis antigen-specific T-cells reveals novel multifunctional features. J Immunol, 2014,193(6):2931-2940.
doi: 10.4049/jimmunol.1401151 URL pmid: 25092889 |
[15] |
Ottenhoff TH . New pathways of protective and pathological host defense to mycobacteria. Trends Microbiol, 2012,20(9):419-428.
doi: 10.1016/j.tim.2012.06.002 URL |
[16] |
Yang CS, Lee JS, Lee HM , et al. Differential cytokine levels and immunoreactivities against Mycobacterium tuberculosis antigens between tuberculous and malignant effusions. Respiratory Medicine, 2008,102(2):280-286.
doi: 10.1016/j.rmed.2007.08.016 URL pmid: 17933504 |
[17] |
Azzurri A, Sow OY, Amedei A , et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microb Infect, 2005,7(1):1-8.
doi: 10.1016/j.micinf.2004.09.004 URL pmid: 15716076 |
[18] |
Riou C, Perez Peixoto B, Roberts L , et al. Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis. PLoS One, 2012,7(5):e36886.
doi: 10.1371/journal.pone.0036886 URL pmid: 22606304 |
[19] |
Bhattacharyya C, Majumder PP, Pandit B . CXCL10 is overexpressed in active tuberculosis patients compared to M.tuberculosis-exposed household contacts. Tuberculosis, 2018,109:8-16.
doi: 10.1016/j.tube.2018.01.005 URL pmid: 29559124 |
[20] |
Nonghanphithak D, Reechaipichitkul W, Namwat W , et al. Chemokines additional to IFN-γ can be used to differentiate among, Mycobacterium tuberculosis, infection possibilities and provide evidence of an early clearance phenotype. Tuberculosis, 2017,105:28-34.
doi: 10.1016/j.tube.2017.04.005 URL pmid: 28610785 |
[21] |
Chung W, Lee K, Jung Y , et al. Serum CXCR3 ligands as biomarkers for the diagnosis and treatment monitoring of tuberculosis. Int J Tuberc Lung Dis, 2015,19(12):1476-1484.
doi: 10.5588/ijtld.15.0325 URL pmid: 26614189 |
[22] |
Lee K, Chung W, Jung Y , et al. CXCR3 ligands as clinical markers for pulmonary tuberculosis. Int J Tuberc Lung Dis, 2015,19(2):191-199.
doi: 10.5588/ijtld.14.0525 URL pmid: 25574918 |
[23] |
Young CW, Dukyong Y, Sung LK , et al. The Usefulness of Serum CXCR3 Ligands for Evaluating the Early Treatment Response in Tuberculosis:A Longitudinal Cohort Study. Medicine, 2016,95(17):e3575.
doi: 10.1097/MD.0000000000003575 URL pmid: 27124069 |
[24] |
Chung WY, Lee KS, Yun JJ , et al. A TB Antigen-Stimulated CXCR3 Ligand Assay for the Diagnosis of Active Pulmonary TB. Chest, 2014,146(2):283-291.
doi: 10.1378/chest.13-1855 URL |
[25] |
Groom JR, Luster AD . CXCR3 in T cell function. Experimental Cell Research, 2011,317(5):620-631.
doi: 10.1016/j.yexcr.2010.12.017 URL |
[26] |
Whiting D, Hsieh G, Yun JJ , et al. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. J Immunol, 2004,172(12):7417-7424.
doi: 10.4049/jimmunol.172.12.7417 URL pmid: 15187119 |
[27] |
Heise CE, Pahuja A, Hudson SC , et al. Pharmacological Characterization of CXC Chemokine Receptor 3 Ligands and a Small Molecule Antagonist. J Pharmacol Exp Ther, 2005,313(3):1263-1271.
doi: 10.1124/jpet.105.083683 URL pmid: 15761110 |
[28] |
Loetscher P, Pellegrino A, Gong JH , et al. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem, 2001,276(5):2986-2991.
doi: 10.1074/jbc.M005652200 URL pmid: 11110785 |
[29] |
Lohmann EM , Koster BF, le Cessie S, et al. Grading of a positive sputum smear and the risk of Mycobacterium tuberculosis transmission. Int J Tuberc Lung Dis, 2012,16(11):1477-1484.
doi: 10.5588/ijtld.12.0129 URL pmid: 22964038 |
[30] |
Rotondi M, Lazzeri E, Romagnani P , et al. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest, 2003,26(2):177-180.
doi: 10.1007/bf03345149 URL pmid: 12739748 |
[31] |
Tworek D, Kuna P, Mlynarski W , et al. MIG (CXCL9), IP-10(CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis. Arch Medical Sci, 2013,9(5):849-853.
doi: 10.5114/aoms.2013.37198 URL pmid: 24273568 |
[32] |
Alessandri AL, Souza AL, Oliveira SC , et al. Concentrations of CXCL8, CXCL9 and sTNFR1 in plasma of patients with pulmonary tuberculosis undergoing treatment. Inflam Res, 2006,55(12):528-533.
doi: 10.1007/s00011-006-5136-9 URL pmid: 17039284 |
[33] |
Singh B, Anbalagan S, Selvaraj P . Regulatory role of CCL5 (rs2280789) and CXCL10 (rs56061981) gene polymorphisms on intracellular CCL5 and CXCL10 expression in pulmonary tuberculosis. Hum Immunol, 2017,78(5/6):430-434.
doi: 10.1016/j.humimm.2017.03.008 URL pmid: 28336310 |
[34] |
Cole KE, Strick CA, Paradis TJ , et al. Interferon-inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3. J Exp Med, 1998,187(12):2009-2021.
doi: 10.1084/jem.187.12.2009 URL pmid: 9625760 |
[1] | He Ping, Wang Yiting, Song Zexuan, Xia Hui, Wang Shengfen, He Wencong, Zheng Yang, Zhao Yanlin. Preliminary study on the gene function of Mycobacterium tuberculosis Rv2333c in macrophages [J]. Chinese Journal of Antituberculosis, 2023, 45(6): 566-574. |
[2] | Ma Zichun, Shang Yuanyuan, Pang Yu, Li Shanshan. Research progress of chemokines in the diagnosis of tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(3): 305-310. |
[3] | LIU Yuan, JU Meng, ZUO Lei, ZHANG Yao-hui, HUANG Yi. Comparative study on results of T-cell spot test for tuberculosis infection of peripheral blood and pleural effusion in tuberculous pleurisy patients complicated with type 2 diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2022, 44(5): 489-493. |
[4] | GONG Dao-fang,LIU Bin-bin,WAN Xiao-jie,YU Yan-yan,TAN Yun-hong. Analysis of risk factors for false-negative results with QuantiFERON-TB Gold In-Tube in the diagnosis of active pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(2): 149-153. |
[5] | Lan WEI,Xue-bo QIN,Xiao-liang DUAN,Hui LI,Yu-zhuo LI,Xin-zhuan JIA,Lei ZHANG. The value of blood interferon-gamma-inducible protein 10 level in assessing the treatment efficacy of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2019, 41(2): 181-185. |
[6] | Fang HUANG,Bo WANG,Guo-lian ZHAO,Hai-dong WANG,Li-yun DANG. Diagnosis value of T lymphocyte detection for non-tuberculous mycobacteria diseases [J]. Chinese Journal of Antituberculosis, 2019, 41(12): 1263-1268. |
[7] | Hao-ran LIU,Ya-li ZHANG,Wei-cong REN,Ling-juan ZHAO,Chuan-you LI,Wei WANG,Meng-qiu GAO. Differential expression and diagnostic value of three cytokines in pleural effusion between pulmonary tuberculosis and lung cancer [J]. Chinese Journal of Antituberculosis, 2018, 40(10): 1046-1050. |
[8] | YANG Xin-ting, LIANG Qing-tao, YANG Yang, LI Qi, CHEN Xiao-you. Study on the value of diagnosis for active pulmonary tuberculosis with the blood ELISA stimulated by three antigens [J]. Chinese Journal of Antituberculosis, 2013, 35(11): 919-922. |
[9] | HUANG Mai-ling,WU Xiao-guang,MA Li-ping,GAO Meng-qiu,CHEN Hong-mei,LIU Rong-mei,XIE Li,ZHANG Li-qun. Clinical analysis on 33 elder patients with acute hematogenous disseminated pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2013, 35(11): 927-929. |
[10] | XU Shu-ming,CHENG Lin-xian,YANG Xuan-qin,XIN Lei,FAN Shang-fei. Analysis of 33 cases of atypical pulmonary tuberculosis ball by CT images [J]. Chinese Journal of Antituberculosis, 2013, 35(11): 930-933. |
[11] | CHEN Qiu-lan,ZHOU Lin,WANG Ni,HU Dai-yu,LI Fang,CHEN Ming-ting. Exploration and effect evaluation of the intervention of providing transportation subsidies to pulmonary tuberculosis patients in two counties in China [J]. Chinese Journal of Antituberculosis, 2012, 34(10): 642-646. |
[12] | LIU Jia-wen, KANG Li-jun, WENG Sheng-feng, ZHU Xin-ying. Diagnostic value of quantitative diagnostic kit for Mycobacterium tuberculosis-IFN-γ release assay [J]. Chinese Journal of Antituberculosis, 2011, 33(9): 600-603. |
[13] | YANG Hua-lin, BAO Chang-lin, BAI Li-qiong, LI Yan-hong, GONG De-hua, TANG Yi, WAN Yan-ping, XIAO Tao, FAN Jiang-jing, CHEN You-fang. Comparison between the effects of interventions of telephone supervision and traditional supervision to the pulmonary TB patients in Hunan rural areas [J]. Chinese Journal of Antituberculosis, 2011, 33(10): 646-650. |
[14] | Cao Wenli,Chen Zheng,Xu Qingjie,Han Yuefei,Wu Yin,Wang Jinling,Xiang Xi,Tu Dehua . Clinical analysis on sputum smear positive conversion in patients with pulmonary tuberculosis during regular treatment [J]. Chinese Journal of Antituberculosis, 2010, 32(9): 92-95. |
[15] | Li Fengjuan,Yan Xiaoting,Nan Qin,Wang Xinhong. Investigation and analysis of the phenomenon of cultural shock of hospital new tuberculosis patients and nursing strategy [J]. Chinese Journal of Antituberculosis, 2010, 32(1): 30-34. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||